Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
ThecaFlex DRx System
DEVICE
2 trials
Sponsors
Alcyone Therapeutics, Inc
, Biogen
Conditions
Muscular Atrophy, Spinal
Scoliosis
Spinal Muscular Atrophy
Spine Deformity
Phase 1
A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)
Recruiting
NCT06555419
Biogen
Muscular Atrophy, Spinal
Start: 2025-01-16
End: 2027-09-30
Target: 78
Updated: 2026-09-03
Unknown Phase
Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
Recruiting
NCT05866419
Alcyone Therapeutics, Inc
Scoliosis, Spinal Muscular Atrophy, Spine Deformity
Start: 2023-11-27
End: 2030-07-01
Target: 90
Updated: 2026-08-19
Related Papers
Clinical evaluation of ThecaFlex DRx, a novel implantable catheter-port for intrathecal nusinersen delivery in spinal muscular atrophy: Initial results from the PIERRE-IDE study.
2026-03-13